BioSpace News Archive

Business

Employer Direct partners with Coca-Cola Consolidated

Employer Direct Healthcare is excited to announce its partnership with Coca-Cola Consolidated

January 3, 2019
·
2 min read
Biotech Bay

REVOLUTION Medicines to Present at the J.P. Morgan Healthcare Conference on January 8, 2019

REVOLUTION Medicines, Inc., a biotechnology company that translates frontier oncology targets to outsmart cancer, today announced that it will make a presentation at the 37th Annual J.P. Morgan Healthcare Conference in San Francisco, CA.

January 3, 2019
·
2 min read
Business

GENFIT and LabCorp Sign a Licensing Agreement to Expand Access to an Innovative Diagnostic Assay for Non-Alcoholic Steatohepatitis (NASH)

Multi-Biomarker Test Will Provide the Clinical Research Community with a Non-Invasive Tool to Identify and Monitor Patients with NASH and Significant Fibrosis

January 3, 2019
·
8 min read
Policy

MYOS RENS Technology Receives a New Patent from the United States Patent and Trademark Office

New Patent Will Significantly Enhance its Fortetropin® Intellectual Property Portfolio

January 3, 2019
·
4 min read
Business

Knopp Biosciences Enters Research Collaboration with Baylor College of Medicine to Develop New Treatments for KCNQ2 Neonatal Encephalopathy

Dr. Ed Cooper, pioneering investigator of serious genetic epilepsies, will evaluate potential drug candidates using Knopp’s library of Kv7.3/7.3 channel activators

January 3, 2019
·
3 min read
Policy

Merck’s KEYTRUDA® (pembrolizumab) Receives Five New Approvals in Japan, Including in Advanced Non-Small Cell Lung Cancer (NSCLC), as Adjuvant Therapy for Melanoma, and in Advanced Microsatellite Instability-High (MSI-H) Tumors

Merck announced today that KEYTRUDA, Merck’s anti-PD-1 therapy, has simultaneously received five new approvals from the Japan Pharmaceuticals and Medical Devices Agency (PMDA), including three expanded uses in advanced non-small lung cancer (NSCLC), one in melanoma, as well as a new indication in advanced microsatellite instability-high (MSI-H) tumors.

January 3, 2019
·
29 min read
Bell Let’s Talk Day is January 30: National awareness campaign begins with Canadians from around the country sharing their stories about mental illness

Multimedia campaign features 41 Canadians from all walks of life relating the impact of mental illness on their lives and inviting you to the mental health conversation

January 3, 2019
·
5 min read
Business

Avanos Medical, Inc. to Present at the 37th Annual J.P. Morgan Healthcare Conference

Avanos Medical, Inc. today announced that Joe Woody, chief executive officer, will present at the 37th Annual J.P. Morgan Healthcare Conference on Thursday Jan. 10 at approximately 8:30 a.m. PT at the Westin St. Francis Hotel in San Francisco.

January 3, 2019
·
1 min read
Biotech Beach

National Pancreatic Cancer Clinical Trials Awareness Month Campaign Sheds Light On Myths And Enrollment Barriers Surrounding Clinical Trials

Pancreatic Cancer Patients Who Participate in Clinical Research Have Better Outcomes

January 3, 2019
·
3 min read
Business

ImaginAb Announces Immuno-Oncology License and Clinical Trial Collaboration with Nektar Therapeutics

Nektar will use ImaginAb’s CD8 ImmunoPET technology to accelerate the development of its investigational immuno-oncology medicines

January 3, 2019
·
3 min read